$SFES
SAFEGUARD SCIENTIFICS INC

2018 Q1 Form 10-Q Financial Statement

#000008611518000044 Filed on April 26, 2018

View on sec.gov

Income Statement

Concept 2018 Q1 2017 Q1
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $5.600M $4.900M
YoY Change 14.29% -5.77%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $5.600M $4.900M
YoY Change 14.29% -5.77%
Operating Profit -$5.589M -$4.947M
YoY Change 12.98% -5.37%
Interest Expense $900.0K -$17.40M
YoY Change -105.17% 70.59%
% of Operating Profit
Other Income/Expense, Net -$1.435M $249.0K
YoY Change -676.31%
Pretax Income -$6.170M -$22.10M
YoY Change -72.08% 43.0%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$6.170M -$22.10M
YoY Change -72.08% 43.0%
Net Earnings / Revenue
Basic Earnings Per Share -$0.30 -$1.08
Diluted Earnings Per Share -$0.30 -$1.08
COMMON SHARES
Basic Shares Outstanding 20.51M shares 20.38M shares
Diluted Shares Outstanding 20.51M shares 20.38M shares

Balance Sheet

Concept 2018 Q1 2017 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $34.29M $32.90M
YoY Change 4.24% -15.86%
Cash & Equivalents $31.29M $30.54M
Short-Term Investments $3.000M $2.400M
Other Short-Term Assets $2.900M $2.300M
YoY Change 26.09% -55.77%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $37.19M $35.24M
YoY Change 5.53% -20.37%
LONG-TERM ASSETS
Property, Plant & Equipment $1.435M $1.789M
YoY Change -19.79% -14.28%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $99.35M $132.3M
YoY Change -24.9% -16.09%
Other Assets $316.0K $121.0K
YoY Change 161.16% -88.33%
Total Long-Term Assets $134.0M $172.9M
YoY Change -22.49% -9.87%
TOTAL ASSETS
Total Short-Term Assets $37.19M $35.24M
Total Long-Term Assets $134.0M $172.9M
Total Assets $171.2M $208.2M
YoY Change -17.75% -11.84%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $237.0K $230.0K
YoY Change 3.04% 4.55%
Accrued Expenses $2.889M $2.017M
YoY Change 43.23% -39.16%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $40.80M
YoY Change
Total Short-Term Liabilities $46.31M $4.022M
YoY Change 1051.42% -23.87%
LONG-TERM LIABILITIES
Long-Term Debt $45.70M $53.00M
YoY Change -13.77% 3.31%
Other Long-Term Liabilities $3.341M $3.581M
YoY Change -6.7% -11.14%
Total Long-Term Liabilities $3.341M $3.581M
YoY Change -6.7% -11.14%
TOTAL LIABILITIES
Total Short-Term Liabilities $46.31M $4.022M
Total Long-Term Liabilities $3.341M $3.581M
Total Liabilities $95.39M $60.59M
YoY Change 57.44% -0.12%
SHAREHOLDERS EQUITY
Retained Earnings -$721.6M -$649.0M
YoY Change 11.19% 4.72%
Common Stock $815.0M $818.1M
YoY Change -0.38% -0.29%
Preferred Stock
YoY Change
Treasury Stock (at cost) $17.44M $21.12M
YoY Change -17.43% -15.5%
Treasury Stock Shares 1.012M shares 1.215M shares
Shareholders Equity $75.80M $147.6M
YoY Change
Total Liabilities & Shareholders Equity $171.2M $208.2M
YoY Change -17.75% -11.84%

Cashflow Statement

Concept 2018 Q1 2017 Q1
OPERATING ACTIVITIES
Net Income -$6.170M -$22.10M
YoY Change -72.08% 43.0%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$6.774M -$6.541M
YoY Change 3.56% 12.0%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities $11.10M $15.10M
YoY Change -26.49% 128.79%
Cash From Investing Activities $11.13M $15.12M
YoY Change -26.36% 128.68%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00 -$10.00K
YoY Change -100.0% -100.18%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$150.0K -$90.00K
YoY Change 66.67% -98.35%
NET CHANGE
Cash From Operating Activities -$6.774M -$6.541M
Cash From Investing Activities $11.13M $15.12M
Cash From Financing Activities -$150.0K -$90.00K
Net Change In Cash $4.207M $8.485M
YoY Change -50.42% -281.5%
FREE CASH FLOW
Cash From Operating Activities -$6.774M -$6.541M
Capital Expenditures $0.00
Free Cash Flow -$6.541M
YoY Change 12.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q1 dei Amendment Flag
AmendmentFlag
false
CY2018Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2018Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2018Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2018
CY2018Q1 dei Document Period End Date
DocumentPeriodEndDate
2018-03-31
CY2018Q1 dei Document Type
DocumentType
10-Q
CY2018Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000086115
CY2018Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
20560746 shares
CY2018Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2018Q1 dei Entity Registrant Name
EntityRegistrantName
SAFEGUARD SCIENTIFICS INC
CY2018Q1 dei Trading Symbol
TradingSymbol
SFE
CY2018Q1 sfe Cash Cash Equivalents And Marketable Securities
CashCashEquivalentsAndMarketableSecurities
34300000 USD
CY2001Q4 sfe Future Annual Payment To Chairman And Chief Executive Officer
FutureAnnualPaymentToChairmanAndChiefExecutiveOfficer
650000 USD
CY2017Q1 sfe Other Comprehensive Income Loss Reclassification Adjustmenton Saleof Equity Method Investments
OtherComprehensiveIncomeLossReclassificationAdjustmentonSaleofEquityMethodInvestments
50000 USD
CY2018Q1 sfe Other Comprehensive Income Loss Reclassification Adjustmenton Saleof Equity Method Investments
OtherComprehensiveIncomeLossReclassificationAdjustmentonSaleofEquityMethodInvestments
82000 USD
CY2017Q1 sfe Other Comprehensive Income Loss Shareof Other Comprehensive Income Lossof Equity Method Investments
OtherComprehensiveIncomeLossShareofOtherComprehensiveIncomeLossofEquityMethodInvestments
-2000 USD
CY2018Q1 sfe Other Comprehensive Income Loss Shareof Other Comprehensive Income Lossof Equity Method Investments
OtherComprehensiveIncomeLossShareofOtherComprehensiveIncomeLossofEquityMethodInvestments
0 USD
CY2018Q1 sfe Partner Companies Not Consolidated In Financial Statements
PartnerCompaniesNotConsolidatedInFinancialStatements
25 nonconsolidated_partner_company
CY2018Q1 sfe Saleof Stock Individual Ownership Percent Maximum
SaleofStockIndividualOwnershipPercentMaximum
0.0499
CY2017Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
155000 USD
CY2018Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
237000 USD
CY2017Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1851000 USD
CY2018Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2889000 USD
CY2017Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-113000 USD
CY2018Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-31000 USD
CY2017Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
812536000 USD
CY2018Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
812796000 USD
CY2018Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
277000 USD
CY2017Q4 us-gaap Advances To Affiliate
AdvancesToAffiliate
22506000 USD
CY2018Q1 us-gaap Advances To Affiliate
AdvancesToAffiliate
17734000 USD
CY2017Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
-105000 USD
CY2018Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
277000 USD
CY2017Q4 us-gaap Assets
Assets
176464000 USD
CY2018Q1 us-gaap Assets
Assets
171222000 USD
CY2017Q4 us-gaap Assets Current
AssetsCurrent
33608000 USD
CY2018Q1 us-gaap Assets Current
AssetsCurrent
37194000 USD
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20751000 USD
CY2018Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
31300000 USD
CY2018Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
31294000 USD
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
28394000 USD
CY2017Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
36879000 USD
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
27087000 USD
CY2018Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
31294000 USD
CY2017Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
8485000 USD
CY2018Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
4207000 USD
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2018Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2018Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
83333000 shares
CY2018Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
83333000 shares
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21573000 shares
CY2018Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21573000 shares
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
2157000 USD
CY2018Q1 us-gaap Common Stock Value
CommonStockValue
2157000 USD
CY2017Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-22049000 USD
CY2018Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-6088000 USD
CY2017Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
40485000 USD
CY2018Q1 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
40829000 USD
CY2017Q4 us-gaap Cost Method Investments
CostMethodInvestments
4096000 USD
CY2018Q1 us-gaap Cost Method Investments
CostMethodInvestments
15190000 USD
CY2017Q1 us-gaap Dilutive Securities Effect On Basic Earnings Per Share Other
DilutiveSecuritiesEffectOnBasicEarningsPerShareOther
20380000 USD
CY2018Q1 us-gaap Dilutive Securities Effect On Basic Earnings Per Share Other
DilutiveSecuritiesEffectOnBasicEarningsPerShareOther
20506000 USD
CY2017Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.08
CY2018Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.30
CY2017Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.08
CY2018Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.30
CY2017Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3321000 USD
CY2018Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2355000 USD
CY2017Q4 us-gaap Equity Method Investments
EquityMethodInvestments
108089000 USD
CY2018Q1 us-gaap Equity Method Investments
EquityMethodInvestments
99353000 USD
CY2017Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4947000 USD
CY2018Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5589000 USD
CY2017Q4 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
4452000 USD
CY2018Q1 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
3044000 USD
CY2017Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-22097000 USD
CY2018Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6170000 USD
CY2017Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-17002000 USD
CY2018Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
2746000 USD
CY2017Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2017Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2018Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2018Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2018Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2017Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
1198000 USD
CY2018Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
2690000 USD
CY2017Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
801000 USD
CY2018Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
798000 USD
CY2017Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
134691000 USD
CY2018Q1 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
132277000 USD
CY2017Q4 us-gaap Liabilities
Liabilities
94668000 USD
CY2018Q1 us-gaap Liabilities
Liabilities
95387000 USD
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
176464000 USD
CY2018Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
171222000 USD
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
45812000 USD
CY2018Q1 us-gaap Liabilities Current
LiabilitiesCurrent
46310000 USD
CY2017Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
45321000 USD
CY2018Q1 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
45736000 USD
CY2018Q1 us-gaap Marketable Securities
MarketableSecurities
3000000 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-90000 USD
CY2018Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-150000 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
15116000 USD
CY2018Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
11131000 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6541000 USD
CY2018Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6774000 USD
CY2017Q1 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
0 USD
CY2018Q1 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
0 USD
CY2018Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2017Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-4947000 USD
CY2018Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-5589000 USD
CY2017Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
316000 USD
CY2018Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
316000 USD
CY2018Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
82000 USD
CY2017Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3535000 USD
CY2018Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3341000 USD
CY2017Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
249000 USD
CY2018Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1435000 USD
CY2017Q1 us-gaap Payments For Advance To Affiliate
PaymentsForAdvanceToAffiliate
6429000 USD
CY2018Q1 us-gaap Payments For Advance To Affiliate
PaymentsForAdvanceToAffiliate
4036000 USD
CY2017Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
100000 USD
CY2018Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
150000 USD
CY2017Q1 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
4476000 USD
CY2018Q1 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
0 USD
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.10
CY2018Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.10
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2018Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2017Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2018Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2017Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4644000 USD
CY2018Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2856000 USD
CY2017Q1 us-gaap Proceeds From Collection Of Advance To Affiliate
ProceedsFromCollectionOfAdvanceToAffiliate
0 USD
CY2018Q1 us-gaap Proceeds From Collection Of Advance To Affiliate
ProceedsFromCollectionOfAdvanceToAffiliate
10500000 USD
CY2017Q1 us-gaap Proceeds From Divestiture Of Businesses And Interests In Affiliates
ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates
15753000 USD
CY2018Q1 us-gaap Proceeds From Divestiture Of Businesses And Interests In Affiliates
ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates
3257000 USD
CY2017Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
10000 USD
CY2018Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
CY2017Q1 us-gaap Proceeds From Sale And Maturity Of Held To Maturity Securities
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
10268000 USD
CY2018Q1 us-gaap Proceeds From Sale And Maturity Of Held To Maturity Securities
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
1410000 USD
CY2017Q1 us-gaap Profit Loss
ProfitLoss
-22097000 USD
CY2018Q1 us-gaap Profit Loss
ProfitLoss
-6170000 USD
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1513000 USD
CY2018Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1435000 USD
CY2017Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
6336000 USD
CY2018Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
0 USD
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-715476000 USD
CY2018Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-721646000 USD
CY2018Q1 us-gaap Severance Costs1
SeveranceCosts1
1100000 USD
CY2018Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-150000 USD
CY2017Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
81796000 USD
CY2018Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
75835000 USD
CY2017Q4 us-gaap Trading Securities
TradingSecurities
3761000 USD
CY2018Q1 us-gaap Trading Securities
TradingSecurities
0 USD
CY2017Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
999000 shares
CY2018Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
1012000 shares
CY2017Q4 us-gaap Treasury Stock Value
TreasuryStockValue
17308000 USD
CY2018Q1 us-gaap Treasury Stock Value
TreasuryStockValue
17441000 USD
CY2017Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20380000 shares
CY2018Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20506000 shares
CY2017Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20380000 shares
CY2018Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20506000 shares

Files In Submission

Name View Source Status
0000086115-18-000044-index-headers.html Edgar Link pending
0000086115-18-000044-index.html Edgar Link pending
0000086115-18-000044.txt Edgar Link pending
0000086115-18-000044-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
sfe-20180331.xml Edgar Link completed
sfe-20180331.xsd Edgar Link pending
sfe-20180331_cal.xml Edgar Link unprocessable
sfe-20180331_def.xml Edgar Link unprocessable
sfe-20180331_lab.xml Edgar Link unprocessable
sfe-20180331_pre.xml Edgar Link unprocessable
sfe-2018xq1.htm Edgar Link pending
sfe-2018xq1xex311.htm Edgar Link pending
sfe-2018xq1xex312.htm Edgar Link pending
sfe-2018xq1xex321.htm Edgar Link pending
sfe-2018xq1xex322.htm Edgar Link pending
Show.js Edgar Link pending